Skip to main content

IVIg Exposure and Renal Failure

    Basic Details
    Date Posted
    Medical Product
    intravenous immunoglobulin (IVIg)
    Health Outcome(s)
    acute kidney failure
    acute renal failure

    Modular program-based one-time assessment of IVIg and subsequent diagnosis of acute renal failure and transfusion procedures among patients with and without a new hemolysis diagnosis after exposure to IVIg. The query was run against the Mini-Sentinel Distributed Database (MSDD) for the time period of January 1, 2006 through December 31, 2012. Modular programs are adaptable standardized programs. Results were generated using Modular Program 6, version 6.0; click here for more information.  Queries were distributed in October 2013. This report includes data from 18 Data Partners.

    If you are using a web page screen reader and are unable to access this document, please use the Contact Us page for assistance or send an email requesting assistance to

    The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

    Additional Details
    FDA Center
    Time Period
    2006 - 2012
    Population / Cohort
    All individuals
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)